Table of Contents Author Guidelines Submit a Manuscript
Letter to the Editor
Journal of Diabetes Research
Volume 2015, Article ID 236238, 10 pages
http://dx.doi.org/10.1155/2015/236238
Research Article

Topically Applied Connective Tissue Growth Factor/CCN2 Improves Diabetic Preclinical Cutaneous Wound Healing: Potential Role for CTGF in Human Diabetic Foot Ulcer Healing

1Sydney Medical School and Charles Perkins Centre, University of Sydney, Sydney, NSW 2006, Australia
2Department of Biomedical Engineering, School of Aerospace, Mechanical and Mechatronic Engineering, University of Sydney, Sydney, NSW 2006, Australia
3Department of Endocrinology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia

Received 27 September 2014; Revised 23 January 2015; Accepted 2 February 2015

Academic Editor: Solomon Tesfaye

Copyright © 2015 F. R. Henshaw et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Bentley and A. Foster, “Multidisciplinary management of the diabetic foot ulcer,” British Journal of Community Nursing, vol. 12, pp. S6–S10, 2007. View at Google Scholar · View at Scopus
  2. R. S. Most and P. Sinnock, “The epidemiology of lower extremity amputations in diabetic individuals,” Diabetes Care, vol. 6, no. 1, pp. 87–91, 1983. View at Publisher · View at Google Scholar · View at Scopus
  3. W. H. Van Houtum and L. A. Lavery, “Outcomes associated with diabetes-related amputations in the Netherlands and in the state of California, USA,” Journal of Internal Medicine, vol. 240, no. 4, pp. 227–231, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. J. S. Wrobel, J. A. Mayfield, and G. E. Reiber, “Geographic variation of lower-extremity major amputation in individuals with and without diabetes in the Medicare population,” Diabetes Care, vol. 24, no. 5, pp. 860–864, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Gordois, P. Scuffham, A. Shearer, A. Oglesby, and J. A. Tobian, “The health care costs of diabetic peripheral neuropathy in the U.S.,” Diabetes Care, vol. 26, no. 6, pp. 1790–1795, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Falanga, “Wound healing and its impairment in the diabetic foot,” The Lancet, vol. 366, no. 9498, pp. 1736–1743, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. W. K. Stadelmann, A. G. Digenis, and G. R. Tobin, “Physiology and healing dynamics of chronic cutaneous wounds,” The American Journal of Surgery, vol. 176, no. 2, supplement 1, pp. 26S–38S, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Bork, “The modular architecture of a new family of growth regulators related to connective tissue growth factor,” FEBS Letters, vol. 327, no. 2, pp. 125–130, 1993. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Daniels, M. van Bilsen, R. Goldschmeding, G. J. Van Der Vusse, and F. A. Van Nieuwenhoven, “Connective tissue growth factor and cardiac fibrosis,” Acta Physiologica, vol. 195, no. 3, pp. 321–338, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Fonseca, G. E. Lindahl, M. Ponticos et al., “A polymorphism in the CTGF promoter region associated with systemic sclerosis,” The New England Journal of Medicine, vol. 357, no. 12, pp. 1210–1220, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Yosimichi, T. Nakanishi, T. Nishida, T. Hattori, T. Takano-Yamamoto, and M. Takigawa, “Ctgf/hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38mapk), and proliferation through a p44/42 mapk/extracellular-signal regulated kinase (erk),” European Journal of Biochemistry, vol. 268, no. 23, pp. 6058–6065, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. D. M. Bradham, A. Igarashi, R. L. Potter, and G. R. Grotendorst, “Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10,” Journal of Cell Biology, vol. 114, no. 6, pp. 1285–1294, 1991. View at Publisher · View at Google Scholar · View at Scopus
  13. L.-D. Liu, H.-J. Shi, L. Jiang et al., “The repairing effect of a recombinant human connective-tissue growth factor in a burn-wounded rhesus-monkey (Macaca mulatta) model,” Biotechnology and Applied Biochemistry, vol. 47, no. 2, pp. 105–112, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. S. M. Twigg and M. E. Cooper, “The time has come to target connective tissue growth factor in diabetic complications,” Diabetologia, vol. 47, no. 6, pp. 965–968, 2004. View at Google Scholar · View at Scopus
  15. S. Wang, M. DeNichilo, C. Brubaker, and R. Hirschberg, “Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy,” Kidney International, vol. 60, no. 1, pp. 96–105, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. K. J. Way, K. Isshiki, K. Suzuma et al., “Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C beta2 activation and diabetes,” Diabetes, vol. 51, no. 9, pp. 2709–2718, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. D. R. Hinton, C. Spee, S. He et al., “Accumulation of NH2-terminal fragment of connective tissue growth factor in the vitreous of patients with proliferative diabetic retinopathy,” Diabetes Care, vol. 27, no. 3, pp. 758–764, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. S. E. Thomson, S. V. McLennan, A. Hennessy et al., “A novel primate model of delayed wound healing in diabetes: dysregulation of connective tissue growth factor,” Diabetologia, vol. 53, no. 3, pp. 572–583, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. S. V. McLennan, X. Y. Wang, V. Moreno, D. K. Yue, and S. M. Twigg, “Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy,” Endocrinology, vol. 145, no. 12, pp. 5646–5655, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. S. V. McLennan, J. Bonner, S. Milne et al., “The anti-inflammatory agent Propolis improves wound healing in a rodent model of experimental diabetes,” Wound Repair and Regeneration, vol. 16, no. 5, pp. 706–713, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. S. E. Thomson, S. V. McLennan, P. D. Kirwan et al., “Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy,” Journal of Diabetes and Its Complications, vol. 22, no. 4, pp. 284–294, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Liu, D. Min, T. Bolton et al., “Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers,” Diabetes Care, vol. 32, no. 1, pp. 117–119, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Xu, S. V. McLennan, L. Lo et al., “Bacterial load predicts healing rate in neuropathic diabetic foot ulcers,” Diabetes Care, vol. 30, no. 2, pp. 378–380, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Tikellis, M. E. Cooper, S. M. Twigg, W. C. Burns, and M. Tolcos, “Connective tissue growth factor is up-regulated in the diabetic retina: amelioration by angiotensin-converting enzyme inhibition,” Endocrinology, vol. 145, no. 2, pp. 860–866, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Chen, D. J. Abraham, X. Shi-Wen et al., “CCN2 (connective tissue growth factor) promotes fibroblast adhesion to fibronectin,” Molecular Biology of the Cell, vol. 15, no. 12, pp. 5635–5646, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. P. V. Peplow, T.-Y. Chung, and G. D. Baxter, “Laser photobiomodulation of wound healing: a review of experimental studies in mouse and rat animal models,” Photomedicine and Laser Surgery, vol. 28, no. 3, pp. 291–325, 2011. View at Google Scholar
  27. I. Cicha, A. Yilmaz, M. Klein et al., “Connective tissue growth factor is overexpressed in complicated atherosclerotic plaques and induces mononuclear cell chemotaxis in vitro,” Arteriosclerosis, Thrombosis, & Vascular Biology, vol. 25, no. 5, pp. 1008–1013, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. H. V. Waugh and J. A. Sherratt, “Macrophage dynamics in diabetic wound healing,” Bulletin of Mathematical Biology, vol. 68, no. 1, pp. 197–207, 2006. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  29. L. A. DiPietro, “Wound healing: the role of the macrophage and other immune cells,” Shock, vol. 4, no. 4, pp. 233–240, 1995. View at Publisher · View at Google Scholar · View at Scopus
  30. R. D. Stout, C. Jiang, B. Matta, I. Tietzel, S. K. Watkins, and J. Suttles, “Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences,” The Journal of Immunology, vol. 175, no. 1, pp. 342–349, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. D. P. Greenwald, S. Shumway, L. S. Zachary et al., “Endogenous versus toxin-induced diabetes in rats: a mechanical comparison of two skin wound-healing models,” Plastic and Reconstructive Surgery, vol. 91, no. 6, pp. 1087–1093, 1993. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Murali, D. R. Hardten, S. DeMartelaere et al., “Effect of topically administered platelet-derived growth factor on corneal wound strength,” Current Eye Research, vol. 13, no. 12, pp. 857–862, 1994. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Li, X. Fu, L. Zhang, Q. Huang, Z. Wu, and T. Sun, “Research of PDGF-BB gel on the wound healing of diabetic rats and its pharmacodynamics,” Journal of Surgical Research, vol. 145, no. 1, pp. 41–48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. J. D. Cameron, A. P. N. Skubitz, and L. T. Furcht, “Type IV collagen and corneal epithelial adhesion and migration: effects of type IV collagen fragments and synthetic peptides on rabbit corneal epithelial cell adhesion and migration in vitro,” Investigative Ophthalmology and Visual Science, vol. 32, no. 10, pp. 2766–2773, 1991. View at Google Scholar · View at Scopus
  35. J. F. Wang, M. E. Olson, D. K. Ball, D. R. Brigstock, and D. A. Hart, “Recombinant connective tissue growth factor modulates porcine skin fibroblast gene expression,” Wound Repair and Regeneration, vol. 11, no. 3, pp. 220–229, 2003. View at Google Scholar
  36. L. Ronnov-Jessen and O. W. Petersen, “Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia,” Laboratory Investigation, vol. 68, no. 6, pp. 696–707, 1993. View at Google Scholar
  37. A. Desmouliere, A. Geinoz, F. Gabbiani, and G. Gabbiani, “Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts,” Journal of Cell Biology, vol. 122, no. 1, pp. 103–111, 1993. View at Publisher · View at Google Scholar · View at Scopus
  38. M. H. Katz, A. F. Alvarez, R. S. Kirsner, W. H. Eaglstein, and V. Falanga, “Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growth,” Journal of the American Academy of Dermatology, vol. 25, no. 6 I, pp. 1054–1058, 1991. View at Publisher · View at Google Scholar · View at Scopus
  39. X. Hu, H. Wang, J. Liu et al., “The role of ERK and JNK signaling in connective tissue growth factor induced extracellular matrix protein production and scar formation,” Archives of Dermatological Research, vol. 305, no. 5, pp. 433–445, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. J.-S. Kim, I.-G. Choi, B.-C. Lee et al., “Neuregulin induces CTGF expression in hypertrophic scarring fibroblasts,” Molecular and Cellular Biochemistry, vol. 365, no. 1-2, pp. 181–189, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. E. Kiwanuka, F. Hackl, E. J. Caterson et al., “CCN2 is transiently expressed by keratinocytes during re-epithelialization and regulates keratinocyte migration in vitro by the ras-MEK-ERK signaling pathway,” Journal of Surgical Research, vol. 185, no. 2, pp. e109–e119, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. M. P. Alfaro, D. L. Deskins, M. Wallus et al., “A physiological role for connective tissue growth factor in early wound healing,” Laboratory Investigation, vol. 93, no. 1, pp. 81–95, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. B. Orcajo, F. Muruzabal, M. C. Isasmendi et al., “The use of plasma rich in growth factors (PRGF-Endoret) in the treatment of a severe mal perforant ulcer in the foot of a person with diabetes,” Diabetes Research and Clinical Practice, vol. 93, no. 2, pp. e65–e67, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Yao, K. Attalla, Y. Ren, M. A. French, and V. R. Driver, “Ease of use, safety, and efficacy of integra bilayer wound matrix in the treatment of diabetic foot ulcers in an outpatient clinical setting: a prospective pilot study,” Journal of the American Podiatric Medical Association, vol. 103, no. 4, pp. 274–280, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. R. Marfella, F. C. Sasso, M. R. Rizzo et al., “Dipeptidyl peptidase 4 inhibition may facilitate healing of chronic foot ulcers in patients with type 2 diabetes,” Experimental Diabetes Research, vol. 2012, Article ID 892706, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus